Hard Gelatin Capsules Market

Global Hard Gelatin Capsules Market Summary:

As per Transpire Insight Analysis, the Global Hard Gelatin Capsules Market size is estimated at USD 3.58 billion in 2025 and is anticipated to reach USD 5.65 billion by 2033, growing at a CAGR of 5.87% from 2026 to 2033. Increasing pharmaceutical production and the growing need for dietary supplements are driving market growth.

The hard gelatin capsules market is very important for the pharmaceutical, nutraceutical and dietary supplement industries. This is because hard gelatin capsules provide a way to deliver the right amount of powders, granules, and other solid medicines. Manufacturers like gelatin capsules because they help make production faster, make sure people get the right dose and make it easier for patients to take their medicine. Hard gelatin capsules are used for various treatments.

In recent years, the hard gelatin capsules market has changed a lot. There is automation in capsule production, and pharmaceutical quality standards are stricter. People are also investing money in new ways to deliver drugs. More people want to stay healthy, so they are taking nutritional supplements. This has increased the demand for gelatin capsules. The hard gelatin capsules market has also grown because more generic medicines are being made and companies are using contract manufacturing services. As pharmaceutical companies develop and improve their products, they will need more high-quality hard gelatin capsules. The demand for gelatin capsules is expected to keep going up.

Global Hard Gelatin Capsules Market Size & Forecast:

• Global Market Size 2025: USD 3.58 Billion
• Expected Market Value (2033): USD 5.65 Billion
• Forecast CAGR (2026–2033): 5.87%
• Leading Region in 2025: Asia Pacific
• Fastest Growing Region: North America
• Key Company Profiles: Lonza (Capsugel), ACG Worldwide, Qualicaps, Suheung, CapsCanada, Bright Pharma Caps, Roxlor, HealthCaps India, Shanxi Guangsheng Medicinal Capsule, Farmacapsulas, Natural Capsules, Nectar Lifesciences, Snail Pharma Industry, Medi-Caps, Erawat Pharma

Key Market Insights:

The worldwide market for hard gelatin capsules is expected to grow further owing to the emphasis of pharma and nutra capsule makers on production efficiency, accurate dosing, and scalable filling processes. Increasing investments in state-of-the-art manufacturing technology and customisations are increasing competition within developed as well as developing markets.

• Standard hard gelatin capsules occupy 44% of the market due to their wide application in prescriptions and OTC medicines.
• Liquid-filled hard gelatin capsules are expected to experience the highest growth with the fastest CAGR of 11.8%, fueled by an increasing demand for improved bioavailability.
• Colored hard gelatin capsules make up 19% of the market due to colour differentiations employed by manufacturers to distinguish the products and create a brand identity.
• Pharmaceutical capsules are 15% of total hard gelatin capsule demand.
• Transparent hard gelatin capsules make up 10% of the market and find increasing applications in nutraceuticals and herbal supplements owing to their clear appearance that attracts customers.
• Enteric-coated capsules occupy 3% of the market owing to growing usage of delivery technology for sensitive active ingredients.
• Major capsule producers are focusing on automation, precise manufacturing, and quality assurance technologies to increase efficiency and reduce production costs.

What are the Key Drivers, Restraints, and Opportunities in the Global Hard Gelatin Capsules Market?

Drivers

The growing output of pharmaceuticals and dietary supplements is one of the driving forces of the hard gelatin capsules market worldwide. Availability of generics, increased consumption of nutraceuticals, as well as increased outsourcing of the production of drugs by CMOs/CDMOs, leads to the need for capsule producers to expand their production capacities. Besides, more and more pharmaceutical companies are turning to capsules as a formulation type, since capsules have precise dosages, are easy to manufacture and improve patients' adherence, leading to higher market acceptance and revenues.

Restraints

The market has to overcome a few difficulties despite its consistent growth. Firstly, there are fluctuations in the cost of raw materials–gelatin– and secondly, there are strict regulations concerning quality and production of pharmaceutical substances. These factors lead to increased cost of production, while the use of animal-derived gelatin still raises concerns regarding sourcing in some regions and among some consumers.

Opportunities

The major growth prospects are the development of sophisticated technology for capsules and exploration of new healthcare markets. Companies have been focusing on developing precise filling machinery, capsule designs and efficient manufacturing facilities to increase productivity. With rapid growth in pharmaceutical manufacturing in Asia Pacific, Latin America and the Middle East, coupled with healthcare investments, there will be numerous growth opportunities for hard gelatin capsule manufacturers in the future.

What Has the Impact of Artificial Intelligence Been on the Global Hard Gelatin Capsules Market?

Artificial intelligence is gradually increasing efficiency in the Global Hard Gelatin Capsules Market through its assistance in production optimisation, quality maintenance, and minimising waste. AI-based monitoring systems enable the analysis of manufacturing processes in real time, detecting variations in production and making it possible for production managers to adjust production and improve the consistency of production batches. The need for increased production efficiency while maintaining high quality standards has made this technology more important in recent years.

Other machine learning algorithms are being applied to determine equipment maintenance requirements, thereby eliminating production downtime. Vision inspection systems using AI algorithms can spot defects such as cracks, filling variations, and different colours in capsules much better than other manual inspection systems. For instance, hard gelatin capsule producers are using AI-based solutions to ensure efficient production and decrease the rate of rejections. Although AI technology offers many benefits, its implementation requires substantial expenditure on equipment, specialists, and integration systems. It becomes hard for small and medium companies to introduce AI technologies due to their high cost and compatibility issues between AI systems and existing production lines. With the development of the digital manufacturing industry, AI is supposed to become one of its key components.

Key Market Trends:

Trends in the hard gelatin capsules market across the globe include an increasing emphasis on product quality, production efficiency, and the provision of customised solutions by pharmaceutical and nutraceutical manufacturers.

• The introduction of automation in the production of gelatin capsules is becoming increasingly common among pharmaceutical manufacturers to increase the rate of production and ensure regulatory compliance.
• More companies are producing liquid-filled gelatin capsules due to the development of formulas that have better bioavailability in complex pharmaceuticals and nutraceuticals.
• Customised printing and colouring of gelatin capsules by their manufacturers is becoming more common to improve their identification and brand image, and increase safety.
• Increasing demand for contract manufacturing organisations (CMOs) and contract development and manufacturing organisations (CDMOs) is leading to increased investments in large-scale capsule manufacturing plants.
• Digital technologies such as artificial intelligence (AI) based visual inspection and real-time process control technology are being adopted to enhance the accuracy of capsule production.
• The number of nutraceutical and dietary supplements sold in capsule form is also increasing due to increased consumer interest in preventive health care and wellness.

Global Hard Gelatin Capsules Market Segmentation

 By Product Type

Standard gelatin capsules possess 44% of the total market share as a result of their extensive application in pharmaceutical formulations, nutraceuticals, and dietary supplements. Being affordable, compatible with a variety of active ingredients and easy to manufacture in bulk makes standard gelatin capsules the market leaders. Coloured gelatin capsules have a 19% market share, as they help with better product identification and branding. Pharmaceutical grade capsules have a 15% share due to increasing demand for quality dosage forms. Transparent gelatin capsules make up 10% of the market share as nutraceutical manufacturers favour them for visible ingredients inside the capsule. Liquid-filled capsules account for 7% of the total market share and are expected to have the highest CAGR at 11.8%, as pharmaceutical firms develop formulations with higher bioavailability. Enteric-coated gelatin capsules have a 3% market share, while others account for 2%. 

By Size

Hard Gelatin Capsules are available in several sizes, including Size 000, Size 00, Size 0, Size 1, Size 2, Size 3, custom sizes, and more. This enables manufacturers to fit the capsules based on their needs in terms of dosage. Size 0 and Size 00 are the most popular choices because they strike a balance between the capacity of the capsule and patient needs. Customised hard gelatin capsule sizes are becoming popular among pharmaceuticals and nutraceuticals due to innovative drug formulations. More product innovations are expected to meet future demands across all types of capsule sizes.

By Application

Pharmaceuticals continue to be the largest application segment since hard gelatin capsules are highly utilised in prescription medicines, generic medicines, and OTC medications. The applications of hard gelatin capsules are also growing across nutraceuticals, dietary supplements, herbal medicines, veterinary medicine, clinical trials, cosmetics, and other healthcare applications. Consumer knowledge about preventive healthcare and investments in drug discovery are driving manufacturers to develop more capsule-based drugs.

By End User

Pharmaceutical companies hold the largest market share because of the high volume of capsule-based medications that they produce. Increasing demand is observed in nutraceutical producers, contract manufacturers (CMOs and CDMOs), veterinary companies, research institutes, hospitals, and healthcare organisations. There has been a rise in outsourcing within the pharmaceutical industry, making the use of contract manufacturers more prevalent, while research institutes have been aiding innovation in capsule technology.

By Distribution Channel

The primary distribution channel for pharmaceutical companies with respect to major capsule manufacturers is direct sales, owing to their reliability in supply, quality control, and purchase agreements. Other notable distribution channels for pharmaceuticals include pharmaceutical distributors, online B2B channels, wholesalers, exporters, contract suppliers, and others.

What are the Key Use Cases Driving the Global Hard Gelatin Capsules Market?

Hard Gelatin capsules are the most common use in the pharmaceutical industry, where they serve as a reliable medium for delivering prescription drugs, generics, and OTC medications. The abundance of regular gelatin capsules results from their widespread use due to accuracy in dosage, productivity in manufacturing, and versatile adaptability to different drug formulas. Apart from their usage in the pharmaceutical industry, the use of hard gelatin capsules has become increasingly popular in nutraceuticals, dietary supplements, herbs and animal health care products. Rising awareness among the population about the need for preventive medicines has led to the emergence of capsule forms of vitamins, minerals, and botanicals.

Possible applications of hard gelatin capsules may include clinical trials, personalised medicine and unique formulas. Liquid-filled and customised hard gelatin capsules could be utilised to create an advanced drug delivery system.

Which Regions are Driving the Global Hard Gelatin Capsules Market Growth?

North America

The fastest-growing region is North America, with a 24% market share and an anticipated 12.6% CAGR. Increasing investments in developing drugs, growing use of capsule nutraceuticals, and growing demand for precise manufacturing technology are helping to drive market growth. The growth of contract manufacturing organisations, along with the increased use of automated and digitalised production facilities, is opening new avenues for capsule manufacturers.In January 2026, Lonza announced it would proceed with the disposal of its Capsules & Health Ingredients business as part of its plans to focus on contract pharmaceutical manufacturing. The business involves manufacturing hard empty gelatin capsules, indicating growing investment and demand in the North American hard gelatin capsule market.

Europe

Europe has a market share of 27%, which has been facilitated by its strict quality standards in the pharmaceutical sector, robust research facilities, and well-established healthcare industry. When compared to Asia Pacific, Europe puts more value on innovation, regulations, and premium pharmaceutical formulations. The existence of top pharmaceutical corporations, rising research and development expenditures, and constant need for premium capsule products have helped Europe drive steady market growth.

Asia-Pacific

The Asia-Pacific region holds the dominant position in the global market of hard gelatin capsules, making up 42% of the total market share, owing to the presence of a large number of drug manufacturers in the region along with the high production of generic drugs and low-cost production capability. The emerging economies of China and India constantly attract investment for the manufacture of drugs, thus increasing the efficiency of the supply chain in the region.In July 2025, Akums Drugs & Pharmaceuticals obtained the Good Manufacturing Practice (GMP) certification for its Haridwar plant from the Brazilian Health Regulatory Agency (ANVISA), increasing its capacity to export pharmaceutical products, including hard gelatin capsules, from India.

Who are the Key Players in the Global Hard Gelatin Capsules Marketand how do they Compete?

The Global Hard Gelatin Capsules Market is moderately competitive, with manufacturers competing on quality, manufacturing efficiency, global distribution, and customised capsule offerings. The competition in the market is based on constant investment in production capacities, compliance, and innovative capsules that can meet the needs of pharmaceutical and nutraceutical organisations. The competition also includes expansion into new regions and establishment of long-term partnerships with drug manufacturers.

Lonza's unique selling points include capsule manufacturing at high levels, research activities, and a global supply chain. The company keeps investing in production technology and sustainable manufacturing and expands its product line to meet changing needs of its customers. Quality and innovative capsule production help it stay active in both pharmaceutical and nutraceutical sectors.ACG offers cost-effective solutions in terms of capsule manufacturing, production of pharmaceutical equipment, and custom capsule products. The company continues to expand its manufacturing capacity and improve its relationships with customers in emerging markets through its localisation strategy. At the same time, Qualicaps, CapsCanada, and Suheung compete in terms of product innovations, quality manufacturing processes and compliance.

Global Hard Gelatin Capsules Market

• Lonza (Capsugel)
• ACG Worldwide
• Qualicaps
• Suheung
• CapsCanada
• Bright Pharma Caps
• Roxlor
• HealthCaps India
• Shanxi Guangsheng Medicinal Capsule
• Farmacapsulas
• Natural Capsules
• Nectar Lifesciences
• Snail Pharma Industry
• Medi-Caps
• Erawat Pharma

Recent Development News

In October 2025, ACG announced a phased USD 200 million investment to build its first hard-shell capsule manufacturing plant in Atlanta, Georgia. This initiative is set to boost regional production capacities as well as customer reach in North America and the production capacity for hard gelatin capsules.

https://www.acg-world.com

In March 2026, Lone Star completed the purchase of Capsugel from Lonza, while Lonza retained a substantial stake in Capsugel. This move was expected to boost the strategic focus of Capsugel in hard and liquid-filled capsule solutions while helping the company expand its business in the future.

https://www.reuters.com

What Strategic Insights Define the Future of the Global Hard Gelatin Capsules Market?

The global hard gelatin capsule market will have steady growth due to increased investment by pharmaceutical firms, nutraceutical companies, and contract manufacturers in the production of high-quality capsules using automation technology and other innovations. The use of innovative capsule filling techniques, along with the need to comply with changing regulations and demands of customers, will be critical in improving productivity. One of the threats to the industry will be the continued dependence on gelatin made from animals and fluctuations in the amount of raw materials. On the other hand, increased pharmaceutical manufacturing in developing countries and rising demand for specific capsule types will be important opportunities for market development.

To enhance their competitive advantage, it is important to focus on the use of digital production technologies and diversification of raw materials. In addition, manufacturers should establish new business relationships with pharmaceutical and nutraceutical companies.

By Product Type

• Standard Gelatin Capsules
• Colored Gelatin Capsules
• Transparent Gelatin Capsules
• Enteric-coated Capsules
• Printed Capsules
• Liquid-filled Capsules
• Pharmaceutical-grade Capsule

By Size

• Size 000
• Size 00
• Size 0
• Size 1
• Size 2
• Size 3
• Customised Sizes

By Application

• Pharmaceuticals
• Nutraceuticals
• Dietary Supplements
• Herbal Products
• Veterinary Medicines
• Clinical Research
• Cosmetics

By End User

• Pharmaceutical Companies
• Nutraceutical Manufacturers
• Contract Manufacturing Organizations
• Veterinary Companies
• Research Institutes
• Hospitals

By Distribution Channel

• Direct Sales
• Pharmaceutical Distributors
• Online B2B Platforms
• Wholesalers
• Exporters
• Contract Suppliers

Regional Outlook

North America

• United States
• Canada
• Mexico

Europe

• Germany
• United Kingdom
• France
• Spain
• Italy
• Rest of Europe

Asia Pacific

• Japan
• China
• Australia & New Zealand
• South Korea
• India
• Rest of Asia Pacific

South America

• Brazil
• Argentina
• Rest of South America

Middle East & Africa

• Saudi Arabia
• United Arab Emirates
• South Africa
• Rest of the Middle East & Africa